State of Wyoming’s Travere Therapeutics TVTX Stock Holding History

State of Wyoming’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$479K	Buy	+8,423	New	+$373K	0.05%	425
2026 Q1	–	Sell	-961	Closed	-$36.7K	–	2044
2025 Q4	$36.7K	Buy	+961	New	+$31.2K	﹤0.01%	1606
2022 Q3	–	Sell	-281	Closed	-$7K	–	1938
2022 Q2	$7K	Sell	281 -1,170	-81%	-$29.4K	﹤0.01%	1692
2022 Q1	$37K	Sell	1,451 -464	-24%	-$12.3K	0.02%	1220
2021 Q4	$59K	Buy	1,915 +672	+54%	+$18.9K	0.03%	1014
2021 Q3	$30K	Buy	1,243 +781	+169%	+$14.3K	0.02%	881
2021 Q2	$7K	Buy	+462	New	+$9.11K	﹤0.01%	1051

Other funds holding TVTX

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wyoming's TVTX Position: Q2 2026 in Review

State of Wyoming opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 8,423 shares worth $479K. The stake represents 0.05% of the portfolio and ranks #425 among its holdings. This is a return to the name: State of Wyoming previously reported a position in TVTX as recently as Q4 2025.

State of Wyoming first reported a position in TVTX in Q2 2021 and has held it in 7 quarters since. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

State of Wyoming held 8,423 shares of Travere Therapeutics worth $479K as of Q2 2026.
Travere Therapeutics was a new State of Wyoming position in Q2 2026.
Travere Therapeutics made up 0.05% of State of Wyoming's portfolio in Q2 2026, its #425 holding.
State of Wyoming first reported a position in Travere Therapeutics in Q2 2021 and has held it in 7 quarters since.
320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.